data-spy="scroll" data-target=".navbar" data-offset="170">
The 17th International Symposium on Neural Transplantation & Repair (INTR), in conjunction with 34th Annual Symposium of the Network for European CNS Transplantation and Restoration (NECTAR) will take place on Oct 28-30, 2024 at the Marina Bay Sands (MBS) in Singapore. This year's symposium is hosted by the Duke-NUS Medical School together with Nanyang Technological University and National University of Singapore.
The INTR symposium represents the international meeting of the American Society for Neural Therapy and Repair (ASNTR), Asia-Pacific Association for Neural Transplantation and Repair (APANTR) and the Network for European CNS Transplantation and Restoration (NECTAR). This year's symposium marks the 40th anniversary since the first INTR symposium was organized by Professor Anders Bjorklund, pioneer of cell therapy for Parkinsons disease, in 1984. Professor Bjorklund will be one of the keynote speakers to the symposium.
This conference will bring together leading scientists, clinicians, and industry representatives from around the world to share their latest findings in gene and cell therapy for neural disorders that will help foster new collaborations. The three-day program will feature keynote lectures, symposia on hot topics, workshops/young investigator colloquia, Industry/patient advocates discussion, and opportunities for oral communications and poster presentations. The scientific program will cover a broad spectrum of stem cell biology, genome editing, preclinical and clinical research and development in cell and gene therapy.
Ticket | Standard 1st Sept onwards |
---|---|
Faculty/Staff | S$700 |
Students/Post Docs | S$400 |
Banquet
Dinner @ MBS on 29 October 2024 |
S$80 |
*The banquet dinner cost is not included in the registration fees.
Day 1: 28 October 2024, Monday |
|
9:00am – 10:00am | Registration & Coffee Break |
10:00am – 10:10am |
Welcome
Address By: Prof Suchun Zhang, Chair, INTR |
10:10am – 11:40am |
Session 1: Clinical Update |
10:10am – 10:30am |
|
10:30am – 10:50am |
|
10:50am – 11:10am |
|
11:10am – 11:40am |
|
11:40am – 12:30pm |
Plenary Lecture: Prof Hongkui Deng, Peking University,
China
(Chemical reprogramming: the path to the next generation of regenerative medicine) Moderator – Prof Su-Chun Zhang |
12:30pm – 1:30pm | Lunch |
1:30pm – 3:00pm |
Session
2: Stem Cell Technology / Organoids |
1:30pm – 1:50pm |
|
1:50pm – 2:10pm |
|
2:10pm – 2:30pm |
|
2:30pm – 3:00pm |
|
3:00pm – 3:30pm | Data Blitz #1 |
3:30pm – 4:00pm | Coffee Break + Poster Session |
4:00pm – 5:30pm |
Session 3: Pre-Clinical Advances #1 |
4:00pm – 4:20pm |
|
4:20pm – 4:40pm |
|
4:40pm – 4:50pm |
|
4:50pm – 5:00pm |
|
5:00pm – 5:10pm |
|
5:10pm – 5:30pm |
|
5:30pm – 5:45pm | Group Photo Taking |
5:45pm – 7:15pm | Cocktail Reception + Poster Session |
End of Day 1 |
Day 2: 29 October 2024, Tuesday |
|
8:30am – 9:00am | Registration |
9:00am – 9:50am |
Plenary Lecture: Prof Anders Björklund, Lund University, Sweden
(Stem cell therapy for Parkinson's disease: Where are we now - and what next?) Moderator – Prof Lachlan Thompson |
9:50am – 10:20am | Coffee Break + Poster Session |
10:20am – 11:50am |
Session 4: Escaping Immune System
|
10:20am – 10:40am |
|
10:40am – 11:00am |
|
11:00am – 11:20am |
|
11:20am – 11:50am |
|
11:50am – 1:20pm |
Session 5: Industry Talks |
11:50am – 12:10pm |
|
12:10pm – 12:30pm |
|
12:30pm – 12:50pm |
|
12:50pm – 1:20pm |
|
1:20pm – 2:20pm | Lunch |
2:20pm – 3:50pm |
Session 6: Disease Mechanism |
2:20pm – 2:40pm |
|
2:40pm – 3:00pm |
|
3:00pm – 3:20pm |
|
3:20pm – 3:50pm |
|
3:50pm – 4:20pm | Coffee Break & Poster Session |
4:20pm – 4:50pm | Data Blitz #2 |
4:50pm – 6:30pm | Free Time |
6:30pm – 9:00pm | Banquet Dinner |
End of Day 2 |
Day 3: 30 October 2024, Wednesday |
|
8:30am – 9:00am | Registration |
9:00am – 9:50am |
Plenary Speaker: Prof Jacob Hanna, Weizmann
Institute of Science, Israel (Synthetic Ex Utero Embryogenesis: from Naive Stem Cells to Complete Embryo Models) Moderator – Asst Prof Alfred Sun |
9:50am – 10:20am | Coffee Break + Poster Session |
10:20am – 11:50am |
Session 7: Pre–Clinical Advances #2 (SCI)
|
10:20am – 10:40am |
|
10:40am – 11:00am |
|
11:00am – 11:20am |
|
11:20am – 11:50am |
|
11:50am – 12:50pm | Lunch |
12:50am – 2:20pm |
Session 8: Neural Degeneration |
12:50pm – 1:10pm |
|
1:10pm – 1:30pm |
|
1:30pm – 1:50pm |
|
1:50pm – 2:20pm |
|
2:20pm – 2:50pm | Data Blitz #3 |
2:50pm – 3:00pm | Closing Address |
End of Symposium |
* Accurate as of 24 October 2024. Programme may be subjected to change without prior notice.
No. | Name | Title | Poster Presentation | Oral Presentation |
---|---|---|---|---|
1 | Ms. Giulia Comini | A systematic review of human stem cell-derived dopaminergic progenitor survival and dopaminergic maturation in Parkinsonian models. | Poster | - |
2 | Dr. Xiaolong Zheng | Human ESC-Derived Dorsal Spinal dI4 GABA Neurons Alleviate Neuropathic Pain and Spasticity After Spinal Cord Injury | Poster | Talk |
3 | Dr. Xiaolong Zheng | Human ESC-Derived Ventral Spinal V3 Glutamate Neurons Contribute to Locomotion Recovery After Spinal Cord Injury | Poster | - |
4 | Dr. Yang Gao | The role of SUMO pathway in neural stem cell reactivation and brain development | Poster | - |
5 | Dr. Quentin Fuchs | Immune-Evasive Strategies for Allogeneic Neural Grafts in Non-Human Primate Models of Huntington’s Disease | Poster | Datablitz |
6 | Mrs. Apirahmee Jeyakumaran | Macaca fascicularis iPSC derived striatal progenitors and organoids for allogeneic grafting in a non human primate model of Huntington disease | Poster | - |
7 | Dr. Nicolas Prudon | Bioreactor-produced iPSCs-derived Dopaminergic Neuron-containing Neural Microtissues Innervate and Normalize Rotational Bias in a Dose-dependent Manner in a Parkinson Rat Model | Poster | Datablitz |
8 | Mr. Anselme Perrier | Selective lowering of mutant-Huntingtin by antisense oligonucleotides (ASOs) in human cortical neurons derived from patient-specific induced pluripotent stem cells (HD-iPSC) | Poster | Talk |
9 | Mr. Francois-Xavier Beau | Investigating Myelin in Amyotrophic Lateral Sclerosis via Transplantation of Patient-iPSC Derived Oligodendrocyte Progenitor Cells into Shiverer Mice | Poster | Datablitz |
10 | Dr. Niamh Moriarty | Are we pouring money down the drain with cell culture media supplements? | Poster | - |
11 | Mr. Andrew Quattrocchi | Isolation of cortical progenitors improves the composition and predictability of human pluripotent stem cell-derived neural transplants in Stroke. | Poster | Datablitz |
12 | Ms. Jennifer Jin | Generating hypothalamic arcuate neurons from human pluripotent stem cells | Poster | Datablitz |
13 | Dr. Qiang Yuan | Regulating the SNpr activity improves motor functions in Parkinson’s Disease mouse models | Poster | Short Talk |
14 | Dr. Cameron Hunt | Advanced modelling of upper motor neuron mnd pathology using human pluripotent stem cells | Poster | Datablitz |
15 | Dr. Jun Nishiyama | Post-Synaptic Tau: Unveiling the Roles in Dendritic Spine Plasticity | Poster | - |
16 | Dr. Tyra Fraser | An improved grafting paradigm for cell therapy-based treatment for Parkinson’s disease | Poster | Datablitz |
17 | Dr. Chiara Pavan | A cloaked human stem cell-derived neural graft evades immune detection in humanised mice | Poster | Talk |
18 | Prof. Jorge Quintero | Five-year outcomes for participants who received autologous reparative peripheral nerve tissue implantation to the basal ganglia at the time they underwent DBS surgery for Parkinson’s disease | Poster | - |
19 | Dr. Arthur Sefiani | Enhancing Neurotrophin-3 activity leads to improvements in respiratory, cognitive, and locomotor function after spinal cord injury | Poster | Datablitz |
20 | Dr. Sherylin Hor | Empowering the Powerhouse: Unveiling Next-Gen Therapeutics for Amyotrophic Lateral Sclerosis through Targeting of Mitochondrial Function | Poster | - |
21 | Ms. Noor Ul Ain Akram | Monoamine modulation mitigates TDP-43 mislocalisation in a targeted drug screen for Amyotrophic Lateral Sclerosis | Poster | Datablitz |
22 | Dr. Dongliang Ma | Arl2 GTPase Associates with the Centrosomal Protein Cdk5rap2 to Regulate Cortical Development via Microtubule Organization | Poster | Datablitz |
23 | Dr. Wai Hon Chooi | Ferroptosis and Mitochondrial Dysfunction in Enterovirus 71- Infected Human Motor Neurons | Poster | Datablitz |
24 | Dr. Jana Bonsberger | Single Cell RNA-Seq for Quality Control of Dopamine Neurons for Autologous Cell Replacement Therapy | Poster | Short Talk |
25 | Dr. Noelia Pelegrina-Hidalgo | Visualising Parkinson's disease at the nanoscale level | Poster | Datablitz |
26 | Dr. Haresh Bhaskar | Tagging proteins involved in neurodegeneration for live-cell super-resolution imaging | Poster | Datablitz |
27 | Ms. Jolie Ho | Dissecting cholesterol metabolism in distinct CNS cell types and the communication between CNS and peripheral systems | Poster | Datablitz |
28 | Mr. Andrew Chai | Depletion of COL1A1-positive non-neuronal cells for improved cortical differentiation of human pluripotent stem cells | Poster | Datablitz |
29 | Dr. Jonathan Teo | Exploring PROX1 dynamics across cell types with GICTrack Dashboard | Poster | - |
30 | Ms. Isabella Jameison Morris | Neuro-restoration Through Targeted Degradation of Alpha-Synuclein | Poster | Datablitz |
31 | Ms. Georgia Eleftheriou | Transplantation of Patient-Derived Neural Progenitors: Unravelling ALS Disease Dynamics and Progression | Poster | Datablitz |
32 | Dr. Kevin Law | Multiscale analysis of regionally-specified astrocytes generated from patient stem cells with genetic forms of Parkinson’s disease | Poster | Datablitz |
Singapore, a captivating city-state situated in Southeast Asia, is a remarkable fusion of diverse cultures, economic prosperity, and a myriad of attractions. With a population of approximately 5.7 million as of 2022, the country reflects its multicultural essence with significant Chinese, Malay, Indian, and other ethnic communities. Its tropical rainforest climate ensures high temperatures and humidity year-round, marked by distinct monsoon seasons.
Singapore's official languages include English, Malay, Mandarin Chinese, and Tamvil, showcasing its rich heritage. The nation's culture comes alive through vibrant festivals and a culinary scene influenced by various traditions.
Singapore boasts a highly developed economy renowned as a global financial hub and a technology and trade leader. The emphasis on education is evident in its well-regarded institutions, and the efficient public transportation system and iconic landmarks like Marina Bay Sands, Gardens by the Bay, Sentosa Island, and the historical charm of Chinatown make it a top destination for travelers worldwide.
If you hold a travel document issued by one of the countries or places listed below, you will require a valid Singapore entry visa to travel to, and seek entry, into Singapore.
Possession of a valid visa does not guarantee entry into Singapore. Please refer to entry requirements for more information.
Please note the following: